BGM Group Ltd. (BGM) vs Lucid Diagnostics Inc. (LUCD)
A side-by-side comparison of BGM Group Ltd. and Lucid Diagnostics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BGM
BGM Group Ltd.
$8.76HealthcareDelayed quote: Oct 6, 2026, 11:02 AM EDT
LUCD
Lucid Diagnostics Inc.
$0.60HealthcareDelayed quote: Oct 6, 2026, 11:00 AM EDT
Total return — BGM vs LUCD
growth of $100 · dividends reinvested · last 2yBGM -94.3% (-76.2%/yr)LUCD -21.1% (-11.1%/yr)LUCD compounded faster over this window
Log scale — wide-divergence pair
BGM LUCD
BGM vs LUCD: by the numbers
- •LUCD is the larger company ($114M vs $111M market cap).
- •Both run net losses; BGM's is the smaller (-52.59% vs -959.76% net margin).
Metrics side by side
Valuation
| Metric | BGM | LUCD |
|---|---|---|
| P/S ratio | N/A | 21.01 |
| P/B ratio | 0.28 | 10.47 |
Profitability
| Metric | BGM | LUCD |
|---|---|---|
| Gross margin | 12.79% | -60.26% |
| Operating margin | -33.18% | -1054.82% |
| Net margin | -52.59% | -959.76% |
| ROE | -5.10% | -478.26% |
| ROIC | -3.19% | -145.10% |
Growth (annualized)
| Metric | BGM | LUCD |
|---|---|---|
| Revenue CAGR (5Y) | -5.39% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.